Cargando…

Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1

Omega-3 fatty acids (ω-3FAs), carotenoids, and vitamin E are important constituents of a healthy diet. While they are present in brain tissue, studies have shown that these key nutrients are depleted in individuals with mild cognitive impairment (MCI) in comparison to cognitively healthy individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Power, Rebecca, Nolan, John M., Prado-Cabrero, Alfonso, Coen, Robert, Roche, Warren, Power, Tommy, Howard, Alan N., Mulcahy, Ríona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354621/
https://www.ncbi.nlm.nih.gov/pubmed/32466168
http://dx.doi.org/10.3390/jpm10020043
_version_ 1783558127620194304
author Power, Rebecca
Nolan, John M.
Prado-Cabrero, Alfonso
Coen, Robert
Roche, Warren
Power, Tommy
Howard, Alan N.
Mulcahy, Ríona
author_facet Power, Rebecca
Nolan, John M.
Prado-Cabrero, Alfonso
Coen, Robert
Roche, Warren
Power, Tommy
Howard, Alan N.
Mulcahy, Ríona
author_sort Power, Rebecca
collection PubMed
description Omega-3 fatty acids (ω-3FAs), carotenoids, and vitamin E are important constituents of a healthy diet. While they are present in brain tissue, studies have shown that these key nutrients are depleted in individuals with mild cognitive impairment (MCI) in comparison to cognitively healthy individuals. Therefore, it is likely that these individuals will benefit from targeted nutritional intervention, given that poor nutrition is one of the many modifiable risk factors for MCI. Evidence to date suggests that these nutritional compounds can work independently to optimize the neurocognitive environment, primarily due to their antioxidant and anti-inflammatory properties. To date, however, no interventional studies have examined the potential synergistic effects of a combination of ω-3FAs, carotenoids and vitamin E on the cognitive function of patients with MCI. Individuals with clinically confirmed MCI consumed an ω-3FA plus carotenoid plus vitamin E formulation or placebo for 12 months. Cognitive performance was determined from tasks that assessed global cognition and episodic memory. Ω-3FAs, carotenoids, and vitamin E were measured in blood. Carotenoid concentrations were also measured in tissue (skin and retina). Individuals consuming the active intervention (n = 6; median [IQR] age 73.5 [69.5–80.5] years; 50% female) exhibited statistically significant improvements (p < 0.05, for all) in tissue carotenoid concentrations, and carotenoid and ω-3FA concentrations in blood. Trends in improvements in episodic memory and global cognition were also observed in this group. In contrast, the placebo group (n = 7; median [IQR] 72 (69.5–75.5) years; 89% female) remained unchanged or worsened for all measurements (p > 0.05). Despite a small sample size, this exploratory study is the first of its kind to identify trends in improved cognitive performance in individuals with MCI following supplementation with ω-3FAs, carotenoids, and vitamin E.
format Online
Article
Text
id pubmed-7354621
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73546212020-07-23 Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1 Power, Rebecca Nolan, John M. Prado-Cabrero, Alfonso Coen, Robert Roche, Warren Power, Tommy Howard, Alan N. Mulcahy, Ríona J Pers Med Article Omega-3 fatty acids (ω-3FAs), carotenoids, and vitamin E are important constituents of a healthy diet. While they are present in brain tissue, studies have shown that these key nutrients are depleted in individuals with mild cognitive impairment (MCI) in comparison to cognitively healthy individuals. Therefore, it is likely that these individuals will benefit from targeted nutritional intervention, given that poor nutrition is one of the many modifiable risk factors for MCI. Evidence to date suggests that these nutritional compounds can work independently to optimize the neurocognitive environment, primarily due to their antioxidant and anti-inflammatory properties. To date, however, no interventional studies have examined the potential synergistic effects of a combination of ω-3FAs, carotenoids and vitamin E on the cognitive function of patients with MCI. Individuals with clinically confirmed MCI consumed an ω-3FA plus carotenoid plus vitamin E formulation or placebo for 12 months. Cognitive performance was determined from tasks that assessed global cognition and episodic memory. Ω-3FAs, carotenoids, and vitamin E were measured in blood. Carotenoid concentrations were also measured in tissue (skin and retina). Individuals consuming the active intervention (n = 6; median [IQR] age 73.5 [69.5–80.5] years; 50% female) exhibited statistically significant improvements (p < 0.05, for all) in tissue carotenoid concentrations, and carotenoid and ω-3FA concentrations in blood. Trends in improvements in episodic memory and global cognition were also observed in this group. In contrast, the placebo group (n = 7; median [IQR] 72 (69.5–75.5) years; 89% female) remained unchanged or worsened for all measurements (p > 0.05). Despite a small sample size, this exploratory study is the first of its kind to identify trends in improved cognitive performance in individuals with MCI following supplementation with ω-3FAs, carotenoids, and vitamin E. MDPI 2020-05-25 /pmc/articles/PMC7354621/ /pubmed/32466168 http://dx.doi.org/10.3390/jpm10020043 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Power, Rebecca
Nolan, John M.
Prado-Cabrero, Alfonso
Coen, Robert
Roche, Warren
Power, Tommy
Howard, Alan N.
Mulcahy, Ríona
Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
title Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
title_full Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
title_fullStr Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
title_full_unstemmed Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
title_short Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
title_sort targeted nutritional intervention for patients with mild cognitive impairment: the cognitive impairment study (cares) trial 1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354621/
https://www.ncbi.nlm.nih.gov/pubmed/32466168
http://dx.doi.org/10.3390/jpm10020043
work_keys_str_mv AT powerrebecca targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT nolanjohnm targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT pradocabreroalfonso targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT coenrobert targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT rochewarren targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT powertommy targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT howardalann targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1
AT mulcahyriona targetednutritionalinterventionforpatientswithmildcognitiveimpairmentthecognitiveimpairmentstudycarestrial1